The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

Cerebral Cortex

Volumn 19, Issue 3, 2009, Pages 497-510

  Dickerson, Bradford C ^a   Bakkour, Akram ^a   Salat, David H ^a   Feczko, Eric ^a   Pacheco, Jenni ^a   Greve, Douglas N ^a   Grodstein, Fran ^b   Wright, Christopher I ^a   Blacker, Deborah ^a   Rosas, H Diana ^a   Sperling, Reisa A ^a   Atri, Alireza ^a   Growdon, John H ^a   Hyman, Bradley T ^a   Morris, John C ^c   Fischl, Bruce ^a,d   Buckner, Randy L ^a,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cerebral cortex; Magnetic resonance imaging; Medial temporal lobe; Parietal cortex

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; DISEASE SEVERITY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MORPHOMETRICS; NERVE DEGENERATION; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; BRAIN MAPPING; CEREBRAL CORTEX; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX;

EID: 59749096829     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhn113     Document Type: Article

References (85)

1. Apostolova LG, Steiner CA, Akopyan GG, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. 2007. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol. 64:1489-1495.
2. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. 1991. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1:103-116.
3. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:631-639.
4. Arriagada PV, Marzloff K, Hyman BT. 1992. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1681-1688.
5. Atri A, Locascio JJ, Lin JM, Yap L, Dickerson BC, Grodstein F, Irizarry MC, Growdon JH, Greenberg SM. 2005. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis. 2:305-312.
6. Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F. 2001. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage. 14:298-309.
7. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS. 2006. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 66:1837-1844.
8. Berg L, McKeel DW, Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, et al. 1998. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 55:326-335.
9. Bobinski M, de Leon MJ, Convit A, De Santi S, Wegiel J, Tarshish CY, Saint Louis LA, Wisniewski HM. 1999. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet. 353:38-40.
10. Bozzali M, Filippi M, Magnani G, Cercignani M, Franceschi M, Schiatti E, Castiglioni S, Mossini R, Falautano M, Scotti G, et al. 2006. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology. 67:453-460.
11. Braak H, Braak E. 1991. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl). 82:239-259.
12. Braak H, Braak E, Bohl J, Bratzke H. 1998. Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl. 54:97-106.
13. Brun A, Gustafson L. 1976. Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Arch Psychiatr Nervenkr. 223:15-33.
14. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ. 2004. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage. 23:724-738.
15. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, et al. 2005. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 25:7709-7717.
16. Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, Jagust WJ, Chui HC, Schuff N, Weiner MW. 2003. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol Aging. 24:537-544.
17. Celone K, Calhoun V, Dickerson BC, Atri A, Chua E, Miller S, Depeau K, Rentz DM, Selkoe DJ, Blacker D, et al. 2006. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci. 26:10222-10231.
18. Coleman P, Federoff H, Kurlan R. 2004. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 63:1155-1162.
19. Coleman PD, Flood DG. 1987. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging. 8:521-545.
20. Csernansky JG, Hamstra J, Wang L, McKeel D, Price JL, Gado M, Morris JC. 2004. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis Assoc Disord. 18:190-195.
21. Dale AM, Fischl B, Sereno MI. 1999. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 9:179-194.
22. DeKosky ST, Scheff SW. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol. 27:457-464.
23. DeKosky ST, Scheff SW, Styren SD. 1996. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration. 5:417-421.
24. Dickerson BC, Fenstermacher E, Salat DH, Wolk DA, Maguire RP, Desikan R, Pacheco J, Quinn BT, Van der Kouwe A, Greve DN, et al. 2008. Detection of cortical thickness correlates of cognitive performance: reliability across MRI scan sessions, scanners, and field strengths. Neuroimage. 39:10-18.
25. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, Beckett LA, deToledo-Morrell L. 2001. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging. 22:747-754.
26. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, et al. 2005. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 65:404-411.
27. Du AT, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW. 2007. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain. 130:1159-1166.
28. Eickhoff SB, Heim S, Zilles K, Amunts K. 2006. Testing anatomically specified hypotheses in functional imaging using cytoarchitectonic maps. Neuroimage. 32:570-582.
29. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, et al. 2006. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 59:512-519.
30. Fischl B, Dale AM. 2000. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 97:11050-11055.
31. Fischl B, Liu A, Dale AM. 2001. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging. 20:70-80.
32. Fischl B, Sereno MI, Dale AM. 1999. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage. 9:195-207.
33. Fischl B, Sereno MI, Tootell RB, Dale AM. 1999. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 8:272-284.
34. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. 2008. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol. 65:113-120.
35. Fotenos AF, Snyder AZ, Girton LE, Morris JC, Buckner RL. 2005. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology. 64:1032-1039.
36. Fox NC, Scahill RI, Crum WR, Rossor MN. 1999. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology. 52:1687-1689.
37. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP. 2002. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry. 73:657-664.
38. Gomez-Isla T, Price JL, McKeel DW, Jr, Morris JC, Growdon JH, Hyman BT. 1996. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 16:4491-4500.
39. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS. 2002. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage. 17:29-46.
40. Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA. 2002. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. 58:1476-1482.
41. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, et al. 2006. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 32:180-194.
42. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1168-1170.
43. Jack CR, Jr, Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, et al. 2002. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 58:750-757.
44. Jack CR, Jr, Petersen RC, O'Brien PC, Tangalos EG. 1992. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 42:183-188.
45. Jack CR, Jr, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E. 1997. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 49:786-794.
46. Juottonen K, Laakso MP, Insausti R, Lehtovirta M, Pitkanen A, Partanen K, Soininen H. 1998. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging. 19:15-22.
47. Kabani N, Le Goualher G, MacDonald D, Evans AC. 2001. Measurement of cortical thickness using an automated 3-D algorithm: a validation study. Neuroimage. 13:375-380.
48. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F. 2003. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage. 18:895-907.
49. Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F. 2004. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage. 23:708-716.
50. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS. 2000. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 47:430-439.
51. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. 1993. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol. 50:949-954.
52. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, et al. 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 55:306-319.
53. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, Goff D, West WC, Williams SC, van der Kouwe AJ, et al. 2003. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry. 60:878-888.
54. Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC. 2005. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex. 15:995-1001.
55. MacDonald D, Kabani N, Avis D, Evans AC. 2000. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage. 12:340-356.
56. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:939-944.
57. Mesulam MM. 1998. From sensation to cognition. Brain. 121(Pt 6):1013-1052.
58. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC. 2006. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 67:446-452.
59. Morris JC. 1993. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 43:2412-2414.
60. Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal LJ, Woodbury P. 1997. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology. 48:1508-1510.
61. Morris JC, McKeel DW, Jr, Fulling K, Torack RM, Berg L. 1988. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 24:17-22.
62. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. 2001. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 58:397-405.
63. Morrison JH, Hof PR. 2002. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res. 136:467-486.
64. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. 2005. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am. 15:869-877.
65. Murphy SN, Mendis ME, Grethe J, Gollub R, Kennedy D, Rosen BR. 2006. A web portal that enables collaborative use of advanced medical image processing and informatics tools through the Biomedical Informatics Research Network (BIRN). AMIA Annu Symp Proc. 579-583.
66. Price JL, Davis PB, Morris JC, White DL. 1991. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 12:295-312.
67. Regeur L. 2000. Increasing loss of brain tissue with increasing dementia: a stereological study of post-mortem brains from elderly females. Eur J Neurol. 7:47-54.
68. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B. 2002. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology. 58:695-701.
69. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RS, Busa E, Morris JC, Dale AM, Fischl B. 2004. Thinning of the cerebral cortex in aging. Cereb Cortex. 14:721-730.
70. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. 2002. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA. 99:4703-4707.
71. Scheff SW, DeKosky ST, Price DA. 1990. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging. 11:29-37.
72. Schleicher A, Palomero-Gallagher N, Morosan P, Eickhoff SB, Kowalski T, de Vos K, Amunts K, Zilles K. 2005. Quantitative architectural analysis: a new approach to cortical mapping. Anat Embryol (Berl). 210:373-386.
73. Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye JA. 2003. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology. 61:487-492.
74. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, et al. 2006. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med. 355:2652-2663.
75. Storandt M, Grant EA, Miller JP, Morris JC. 2002. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 59:1034-1041.
76. Storandt M, Grant EA, Miller JP, Morris JC. 2006. Progression in mild cognitive impairment (MCI) and PreMCI: a comparison of diagnostic criteria. Neurology. 67:467-473.
77. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 30:572-580.
78. Thal LJ, Grundman M, Golden R. 1986. Alzheimer's disease: a correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam. Neurology. 36:262-264.
79. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, et al. 2003. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci. 23:994-1005.
80. Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW. 2001. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex. 11:1-16.
81. Tomlinson BE, Blessed G, Roth M. 1968. Observations on the brains of non-demented old people. J Neurol Sci. 7:331-356.
82. Van Hoesen GW, Hyman BT, Damasio AR. 1986. Cell-specific pathology in neural systems of the temporal lobe in Alzheimer's disease. Prog Brain Res. 70:321-335.
83. Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR, Jr. 2008. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology. 70:512-520.
84. Wright CI, Dickerson BC, Feczko E, Negeira A, Williams D. 2007. A functional magnetic resonance imaging study of amygdala responses to human faces in aging and mild Alzheimer's disease. Biol Psychiatry. 62:1388-1395.
85. Wright CI, Feczko E, Dickerson B, Williams D. 2007. Neuroanatomical correlates of personality in the elderly. Neuroimage. 35:263-272.